標(biāo)題: Titlebook: Cancer Immunology; A Translational Medi Nima Rezaei Book 2020Latest edition Springer Nature Switzerland AG 2020 Cancer immunotherapy.Tumor [打印本頁] 作者: ergonomics 時(shí)間: 2025-3-21 18:43
書目名稱Cancer Immunology影響因子(影響力)
書目名稱Cancer Immunology影響因子(影響力)學(xué)科排名
書目名稱Cancer Immunology網(wǎng)絡(luò)公開度
書目名稱Cancer Immunology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cancer Immunology被引頻次
書目名稱Cancer Immunology被引頻次學(xué)科排名
書目名稱Cancer Immunology年度引用
書目名稱Cancer Immunology年度引用學(xué)科排名
書目名稱Cancer Immunology讀者反饋
書目名稱Cancer Immunology讀者反饋學(xué)科排名
作者: Conducive 時(shí)間: 2025-3-21 22:04
Role of Innate Immunity in Cancers and Antitumor Response,te, where they can recognize the transformed cells. Recognition of tumor cells is mediated by receptors expressed on the surface of innate immune cells, such as NK receptors, CLRs, as well as phagocytosis receptors expressed on APCs. Additionally, factors released from stressed cells at the tumor mi作者: Inelasticity 時(shí)間: 2025-3-22 01:22 作者: Decibel 時(shí)間: 2025-3-22 05:10
B-Cells in Cancer Immunology: For or Against Cancer Growth?,rgent roles in T-cell differentiation and effector function. Over the years, the role of B-cells in the host immune response to malignancy has been overshadowed by our focus on T-cells and remains to be fully defined. While studies on B-cells in immune responses have been focused on antigen presenta作者: Atheroma 時(shí)間: 2025-3-22 11:35
The Roles of CD4+ T-Cells in Tumor Immunity,. T cells constitute the effector arm of the adaptive anti-tumor immunity. Increasing evidence indicates that among the subsets of T cells, CD4+ T cells are required for triggering both humoral and cell-mediated immune response and significantly contribute to tumor protection. The identification and作者: scrutiny 時(shí)間: 2025-3-22 13:36
Regulatory T-Cells and Th17 Cells in Tumor Microenvironment,ronments appears to be largely true, but an increasing body of evidence suggests that certain types of cancer are formed in inflammatory conditions and tumors produce a number of inflammatory mediators. The tolerogenic nature of the tumor microenvironment is reflected in the presence of a large numb作者: scrutiny 時(shí)間: 2025-3-22 20:07
T-Cell Metabolism and Its Dysfunction Induced by Cancer,nction of T-cells..We review how T-cells change their metabolism to (a) obtain energy throughout the different states of maturation (naive, memory, and effector cell), (b) form construction blocks to proliferate (carbon skeleton and nitrogen for nitrogen bases), and (c) live during a long-term perio作者: 單獨(dú) 時(shí)間: 2025-3-22 22:04
The Role of Exhaustion in Tumor-Induced T-Cell Dysfunction in Cancer,nity. However, despite homing into tumor sites, infiltrating T-cells seldom control tumor growth, and T-cell-directed immunotherapy has not been successful. Initially, anergy was thought to be responsible for the nonresponsiveness of T-cells to tumors. Nevertheless, cancer has been hypothesized to b作者: 顯示 時(shí)間: 2025-3-23 02:43 作者: 驕傲 時(shí)間: 2025-3-23 08:02 作者: 無力更進(jìn) 時(shí)間: 2025-3-23 12:55 作者: Genistein 時(shí)間: 2025-3-23 17:43 作者: 斜 時(shí)間: 2025-3-23 21:13
Role of Cytokines in Tumor Immunity and Immune Tolerance to Cancer,une responses. While certain cytokines produced in the tumor microenvironment can inhibit tumor growth, others promote tumor growth and progression. Here, we review the roles of antitumor cytokines (IL-12 and IL-27) with potential preclinical and clinical applications, as well highlight pro-tumor cy作者: NOVA 時(shí)間: 2025-3-24 00:53 作者: FUME 時(shí)間: 2025-3-24 05:28 作者: 建筑師 時(shí)間: 2025-3-24 08:05 作者: 否決 時(shí)間: 2025-3-24 14:36 作者: 一大塊 時(shí)間: 2025-3-24 16:01
Endoplasmic Reticulum Stress and Autophagy in Cancer, of the ER homeostasis. Nutrient deprivation, hypoxia, and calcium depletion are some conditions which can compromise the homeostasis of this compartment. To overcome the imbalanced ER protein-folding capacity, cells have evolved an evolutionary conserved signal transduction pathway called unfolded 作者: Euthyroid 時(shí)間: 2025-3-24 20:44
Prognostic Value of Innate and Adaptive Immunity in Cancers,y, how cancer cells progress and acquire their metastatic ability still remains debated. Tumors are heterogeneous cellular systems whose growth depends on dynamical interactions among the cancer cells, and between cells and the constantly changing microenvironment. Several types of immune cells, inc作者: 媽媽不開心 時(shí)間: 2025-3-25 02:28
https://doi.org/10.1007/978-3-319-54964-4stem can recognize tumor cells and mediate antigen-specific tumor rejection under certain condition. The molecular and cellular basis of immune recognition and antitumor immunity is now better understood. In addition, it is now evident that tumors may mediate immunosuppression through various solubl作者: Ventricle 時(shí)間: 2025-3-25 05:30
https://doi.org/10.1007/978-3-319-54964-4te, where they can recognize the transformed cells. Recognition of tumor cells is mediated by receptors expressed on the surface of innate immune cells, such as NK receptors, CLRs, as well as phagocytosis receptors expressed on APCs. Additionally, factors released from stressed cells at the tumor mi作者: Deceit 時(shí)間: 2025-3-25 10:59
https://doi.org/10.1007/978-3-319-54964-4 immune cells infiltrating tumors are integral component of the TME. While it would be expected that immune cells exert mainly a protective role for the host against tumor, it is now well established that tumor cells can strongly influence the functions of immune cells, subverting their biological p作者: Synovial-Fluid 時(shí)間: 2025-3-25 12:53
Rune Dahl Fitjar,Bram Timmermansrgent roles in T-cell differentiation and effector function. Over the years, the role of B-cells in the host immune response to malignancy has been overshadowed by our focus on T-cells and remains to be fully defined. While studies on B-cells in immune responses have been focused on antigen presenta作者: 鑲嵌細(xì)工 時(shí)間: 2025-3-25 16:20
Lars Coenen,Stephanie Campbell,John Wiseman. T cells constitute the effector arm of the adaptive anti-tumor immunity. Increasing evidence indicates that among the subsets of T cells, CD4+ T cells are required for triggering both humoral and cell-mediated immune response and significantly contribute to tumor protection. The identification and作者: peritonitis 時(shí)間: 2025-3-25 21:01 作者: 祖?zhèn)髫?cái)產(chǎn) 時(shí)間: 2025-3-26 03:48
Rune Dahl Fitjar,Bram Timmermansnction of T-cells..We review how T-cells change their metabolism to (a) obtain energy throughout the different states of maturation (naive, memory, and effector cell), (b) form construction blocks to proliferate (carbon skeleton and nitrogen for nitrogen bases), and (c) live during a long-term perio作者: Spartan 時(shí)間: 2025-3-26 06:22 作者: Overstate 時(shí)間: 2025-3-26 11:13 作者: 貞潔 時(shí)間: 2025-3-26 13:10 作者: 核心 時(shí)間: 2025-3-26 17:40 作者: 返老還童 時(shí)間: 2025-3-26 23:26
https://doi.org/10.1007/978-3-319-34087-6proteins to CD8. T-lymphocytes. In tumor cells, MHC class I (MHC-I) molecules may present peptides derived from tumor-associated antigens (TAAs), which are new proteins expressed or overexpressed in tumor cells. Presentation of these new peptides may allow recognition and destruction of tumor cells 作者: 費(fèi)解 時(shí)間: 2025-3-27 02:18 作者: Nutrient 時(shí)間: 2025-3-27 07:32
The Kingdom of Bahrain: A Troubled Allyal functions associated with tumor development, they are ideal targets for investigating tumor progression, prognosis, therapy, and susceptibility. In this chapter, the mechanism through which chemokines control the different stages of oncogenesis is described. At first, a detailed description on th作者: Cantankerous 時(shí)間: 2025-3-27 12:52 作者: 我不死扛 時(shí)間: 2025-3-27 15:42
New Beginning in US-Muslim Relationsmoral growth and metastasis. The dual action of the immune system in malignancies has given rise to the modern concept of cancer immunoediting which includes three Es of elimination, equilibrium, and escape. During the elimination phase, the immune system attempts to get rid of cancer by launching a作者: 強(qiáng)制令 時(shí)間: 2025-3-27 21:10
Libya: A Convergence of Interestsomplexity and aberrant cell death and survival signaling pathways. Resistance to cell death induction has long been recognized as a hallmark of cancer. Thus, understanding of the underlying molecular events regulating different cell death mechanisms such as apoptosis has provided new possibilities f作者: Finasteride 時(shí)間: 2025-3-28 01:15 作者: Synchronism 時(shí)間: 2025-3-28 03:57 作者: Eosinophils 時(shí)間: 2025-3-28 07:38 作者: Angiogenesis 時(shí)間: 2025-3-28 13:47 作者: 外星人 時(shí)間: 2025-3-28 16:57 作者: Overstate 時(shí)間: 2025-3-28 21:53
978-3-030-30847-6Springer Nature Switzerland AG 2020作者: Liability 時(shí)間: 2025-3-28 22:56
https://doi.org/10.1007/978-3-319-54964-4rn result in significant therapeutic effects in a variety of cancers. Moreover, immunotherapy is being established as a major class of drugs for cancer therapy. This chapter will review the scope of the cancer problem, describe the basis of antitumor immunity, and introduce the concept of tumor immunotherapy.作者: 詞匯 時(shí)間: 2025-3-29 06:18 作者: critic 時(shí)間: 2025-3-29 10:44 作者: Asseverate 時(shí)間: 2025-3-29 13:52 作者: 細(xì)查 時(shí)間: 2025-3-29 18:06
M. Meisenbach,T. Allmendinger,C.-P. Maksents an important necessity and will pave the road to novel therapeutic strategies to fight malignancies. In this chapter we will discuss novel findings about the therapeutic tools which are based on the pharmacological manipulation of tumor-associated pDCs.作者: Exhilarate 時(shí)間: 2025-3-29 21:15
Introduction on Cancer Immunology and Immunotherapy,rn result in significant therapeutic effects in a variety of cancers. Moreover, immunotherapy is being established as a major class of drugs for cancer therapy. This chapter will review the scope of the cancer problem, describe the basis of antitumor immunity, and introduce the concept of tumor immunotherapy.作者: HERTZ 時(shí)間: 2025-3-30 02:46
Regulatory T-Cells and Th17 Cells in Tumor Microenvironment,nd cancer types significantly affect the numbers and functions of the two T-cell subsets in tumors. Tumor microenvironments that regulate the population and function of FoxP3. T-cells and Th17 cells in tumors are discussed in this article.作者: 刪減 時(shí)間: 2025-3-30 05:11 作者: 不吉祥的女人 時(shí)間: 2025-3-30 11:49 作者: Optimum 時(shí)間: 2025-3-30 14:18
Role of Plasmacytoid Dendritic Cells in Cancer,sents an important necessity and will pave the road to novel therapeutic strategies to fight malignancies. In this chapter we will discuss novel findings about the therapeutic tools which are based on the pharmacological manipulation of tumor-associated pDCs.作者: 半圓鑿 時(shí)間: 2025-3-30 17:32
aspects in order to educate clinicians in the clinical impl.This book focusing on the immunopathology of cancers is published as part of the three-volume Springer series .Cancer Immunology., which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Read作者: Calibrate 時(shí)間: 2025-3-30 23:31
Rune Dahl Fitjar,Bram Timmermansd effector cell), (b) form construction blocks to proliferate (carbon skeleton and nitrogen for nitrogen bases), and (c) live during a long-term period. Finally, we also review how the metabolism of T-cell is affected by the tumor microenvironment.作者: Obverse 時(shí)間: 2025-3-31 02:25 作者: 掙扎 時(shí)間: 2025-3-31 05:44
Apoptosis and Cancer,or targeted interference of these pathways. This chapter highlights the significant signaling pathways of apoptosis and its relevant therapeutic targets and summarizes the current state of development of specific modulators of cell death and the overall outcome of this group of novel therapeutics in various phases of clinical trials.作者: 語言學(xué) 時(shí)間: 2025-3-31 11:21
Libya: A Convergence of Interestsor targeted interference of these pathways. This chapter highlights the significant signaling pathways of apoptosis and its relevant therapeutic targets and summarizes the current state of development of specific modulators of cell death and the overall outcome of this group of novel therapeutics in various phases of clinical trials.作者: 案發(fā)地點(diǎn) 時(shí)間: 2025-3-31 17:02 作者: 走路左晃右晃 時(shí)間: 2025-3-31 20:37 作者: Coeval 時(shí)間: 2025-3-31 23:31
The Kingdom of Bahrain: A Troubled Allydevelopment. This point of view is in contrast with what was reported in some cancer animal models in which the activation of some inflammasome complexes is associated with tumor protection. Therefore, more studies are needed to understand the biology of the inflammasome in cancer and hence, explore its therapeutic potential.作者: 胰島素 時(shí)間: 2025-4-1 02:03 作者: Locale 時(shí)間: 2025-4-1 07:43
Role of Chemokines and Chemokine Receptors in Cancer,c and innate immune responses against the tumor, along with their impact on the tumor prognosis, is discussed. Finally, we extensively reported on various studies of chemokine gene polymorphisms associated with clinical prognosis and commented on the use of chemokine-derived molecules as anticancer therapeutic tools.
